SHELBY BLEVINS: Open Payments
NPI 1982302618 · MOUNT AIRY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 15 payments from 9 companies in 2025. Trend: 2023 $384 · 2024 $592 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Viatris Specialty LLC | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: REXULTI, Ozempic, VOQUEZNA, LEQVIO, YUPELRI, JOURNAVX, HETLIOZ, Veozah.
Industry payments across NC — which companies pay providers there.
